Georgia Melagraki

Author PubWeight™ 11.84^‹?›

Top papers

Rank	Title	Journal	Year	PubWeight™‹?›
1	Collaborative development of predictive toxicology applications.	J Cheminform	2010	1.91
2	A novel QSAR model for predicting induction of apoptosis by 4-aryl-4H-chromenes.	Bioorg Med Chem	2006	1.04
3	Identification of putative estrogen receptor-mediated endocrine disrupting chemicals using QSAR- and structure-based virtual screening approaches.	Toxicol Appl Pharmacol	2013	0.96
4	Ligand-based virtual screening procedure for the prediction and the identification of novel β-amyloid aggregation inhibitors using Kohonen maps and Counterpropagation Artificial Neural Networks.	Eur J Med Chem	2010	0.85
5	A novel QSAR model for predicting the inhibition of CXCR3 receptor by 4-N-aryl-[1,4] diazepane ureas.	Eur J Med Chem	2008	0.83
6	Investigation of substituent effect of 1-(3,3-diphenylpropyl)-piperidinyl phenylacetamides on CCR5 binding affinity using QSAR and virtual screening techniques.	J Comput Aided Mol Des	2006	0.82
7	Functionalized 4-hydroxy coumarins: novel synthesis, crystal structure and DFT calculations.	Molecules	2011	0.81
8	Rational design, efficient syntheses and biological evaluation of N,N'-symmetrically bis-substituted butylimidazole analogs as a new class of potent Angiotensin II receptor blockers.	Eur J Med Chem	2013	0.81
9	A novel simple QSAR model for the prediction of anti-HIV activity using multiple linear regression analysis.	Mol Divers	2006	0.81
10	A combined LS-SVM & MLR QSAR workflow for predicting the inhibition of CXCR3 receptor by quinazolinone analogs.	Mol Divers	2009	0.79
11	Design and synthesis of novel quinolinone-3-aminoamides and their alpha-lipoic acid adducts as antioxidant and anti-inflammatory agents.	J Med Chem	2007	0.78
12	Molecular modeling on pyrimidine-urea inhibitors of TNF-α production: an integrated approach using a combination of molecular docking, classification techniques, and 3D-QSAR CoMSIA.	J Chem Inf Model	2012	0.78
13	Comparative study of the AT₁ receptor prodrug antagonist candesartan cilexetil with other sartans on the interactions with membrane bilayers.	Biochim Biophys Acta	2012	0.77
14	Rational drug design paradigms: the odyssey for designing better drugs.	Comb Chem High Throughput Screen	2015	0.75
15	Stability and binding effects of silver(I) complexes at lipoxygenase-1.	J Enzyme Inhib Med Chem	2014	0.75
16	Consensus Predictive Model for the prediction of Human K562 Cell Growth Inhibition through Enalos Cloud Platform.	ChemMedChem	2017	0.75
17	Searching for novel Janus kinase-2 inhibitors using a combination of pharmacophore modeling, 3D QSAR studies and virtual screening.	Mini Rev Med Chem	2016	0.75
18	Advances in Cheminformatics: Drug Discovery, Computational Toxicology and Nanomaterials (Part II).	Comb Chem High Throughput Screen	2015	0.75